Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (241-250 of 455) with videos related to

Pageof 46
Sort By:
Plos One|June 8, 2021
Well-being during COVID-19 pandemic: A comparison of individuals with minoritized sexual and gender identities and cis-heterosexual individualsPichit Buspavanich, Sonia Lech, Eva Lermer, et al.
Archives of Gynecology and Obstetrics|September 15, 2020
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC statusTheresa Vilsmaier, Helene Hildegard Heidegger, Lennard Schröder, et al.
Cancer Management and Research|October 17, 2019
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biologyBastian Czogalla, Maja Kahaly, Doris Mayr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancerKonstantina Panoutsopoulou, Paraskevi Magkou, Tobias Dreyer, et al.
Breast (Edinburgh, Scotland)|November 4, 2021
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspectiveMarie Forster, Rachel Wuerstlein, Alexander Koenig, et al.
Oncotargets and Therapy|September 24, 2014
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumElena Ioana Braicu, Hrvoje Luketina, Rolf Richter, et al.
Breast Care (Basel, Switzerland)|June 12, 2018
Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young PatientsMaximiliane Burgmann, Kerstin Hermelink, Alex Farr, et al.
Oncotarget|November 16, 2017
Loss of <i>BRCA1</i> promotor hypermethylation in recurrent high-grade ovarian cancerKatharina Prieske, Stefan Prieske, Simon A Joosse, et al.
Archives of Gynecology and Obstetrics|November 3, 2018
Delayed interval delivery in multiple gestations: the Munich experienceThomas Kolben, Daniel Fischer, Ina Ruehl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucoseJörg Schwarz-Dose, Michael Untch, Reinhold Tiling, et al.
Pageof 46

Showing results (241-250 of 455) with videos related to

Sort By:
Pageof 46
Plos One|June 8, 2021
Well-being during COVID-19 pandemic: A comparison of individuals with minoritized sexual and gender identities and cis-heterosexual individualsPichit Buspavanich, Sonia Lech, Eva Lermer, et al.
Archives of Gynecology and Obstetrics|September 15, 2020
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC statusTheresa Vilsmaier, Helene Hildegard Heidegger, Lennard Schröder, et al.
Cancer Management and Research|October 17, 2019
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biologyBastian Czogalla, Maja Kahaly, Doris Mayr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancerKonstantina Panoutsopoulou, Paraskevi Magkou, Tobias Dreyer, et al.
Breast (Edinburgh, Scotland)|November 4, 2021
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspectiveMarie Forster, Rachel Wuerstlein, Alexander Koenig, et al.
Oncotargets and Therapy|September 24, 2014
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumElena Ioana Braicu, Hrvoje Luketina, Rolf Richter, et al.
Breast Care (Basel, Switzerland)|June 12, 2018
Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young PatientsMaximiliane Burgmann, Kerstin Hermelink, Alex Farr, et al.
Oncotarget|November 16, 2017
Loss of <i>BRCA1</i> promotor hypermethylation in recurrent high-grade ovarian cancerKatharina Prieske, Stefan Prieske, Simon A Joosse, et al.
Archives of Gynecology and Obstetrics|November 3, 2018
Delayed interval delivery in multiple gestations: the Munich experienceThomas Kolben, Daniel Fischer, Ina Ruehl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucoseJörg Schwarz-Dose, Michael Untch, Reinhold Tiling, et al.
Pageof 46